ScholarX: Browsing ScholarWorks

Browsing by Herrera, AF[Herrera, Alex Francisco]Author

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

Sort by: In order: Results/Page Authors/Record:

Showing results 1 to 2 of 2

SCIESCOPUS

KEYFORM-008: Coformulated favezelimab and pembrolizumab (MK4280A) versus chemotherapy in relapsed/refractory classical Hodgkin lymphoma.

Lavie, D[Lavie, David]; Timmerman, J[Timmerman, John]; Sanz, RG[Sanz, Ramon Garcia]; Kim, WS[Kim, Won Seog]; Kim, TM[Kim, Tae Min]; Avigdor, A[Avigdor, Abraham]; Dierickx, D[Dierickx, Daan]; Jagadeesh, D[Jagadeesh, Deepa]; Molin, D[Molin, Daniel]; Ozcan, M[Ozcan, Muhit], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS

SCIESCOPUS

Randomized phase 2 trial of polatuzumab vedotin (pola) with bendamustine and rituximab (BR) in relapsed/refractory (r/r) FL and DLBCL.

Sehn, LH[Sehn, Laurie Helen]; Kamdar, M[Kamdar, Manali]; Herrera, AF[Herrera, Alex Francisco]; McMillan, A[McMillan, Andrew]; Flowers, C[Flowers, Christopher]; Kim, WS[Kim, Won Seog]; Kim, TM[Kim, Tae Min]; Ozcan, M[Ozcan, Muhit]; Demeter, J[Demeter, Judit]; Hertzberg, M[Hertzberg, Mark], et al.

ArticleIssue Date2018CitationJOURNAL OF CLINICAL ONCOLOGY, v.36, no.15PublisherAMER SOC CLINICAL ONCOLOGY

STATISTICS: Total View:; Daily View:

RSS_1.0 RSS_2.0 ATOM_1.0

(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREA samsunglib@skku.edu

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Browsing by Herrera, AF[Herrera, Alex Francisco]Author

BROWSE